Hypertensive heart disease with heart failure
Methodology & AI Transparency ⓘ
Hypertensive heart disease with heart failure Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Hypertensive heart disease with heart failure—coded clinically as I11.0 across Blood Pressure guidelines—combines vascular stiffness assessment [Hypertensive heart disease with heart failure I11.0] with structured follow-up of Home Seated Blood in Hypertensive heart disease with heart failure (I11.0: Pressure) (< 120/75 mmHg (I11.0)).
- 2 Real-world patient consensus: Clinical coding for Hypertensive heart disease with heart failure uses ICD-10 I11.0 across Blood Pressure specialty care.
- 3 Typical cash cost range: Differential triage of Hypertensive heart disease with heart failure (I11.0) utilizes vascular stiffness assessment [Hypertensive heart disease with heart failure I11.0].
- 4 Top reported side effects / signs: Key Blood Pressure biomarkers for Hypertensive heart disease with heart failure (I11.0): Urine Albumin-to-Creatinine Ratio [Hypertensive heart disease with heart failure I11.0] & Home Seated Blood in Hypertensive heart disease with heart failure (I11.0: Pressure) (< 120/75 mmHg (I11.0)).
Ask our AI Specialists anything about Hypertensive heart disease with heart failure
What Is Hypertensive heart disease with heart failure?
Hypertensive heart disease with heart failure—coded clinically as I11.0 across Blood Pressure guidelines—combines vascular stiffness assessment [Hypertensive heart disease with heart failure I11.0] with structured follow-up of Home Seated Blood in Hypertensive heart disease with heart failure (I11.0: Pressure) (< 120/75 mmHg (I11.0)).
Pathophysiology, Underlying Causes & Clinical Presentation
Hypertensive heart disease with heart failure (I11.0) alters blood pressure homeostasis through intimal-medial vascular remodeling [Hypertensive heart disease with heart failure I11.0]; clinical remission targets Home Seated Blood in Hypertensive heart disease with heart failure (I11.0: Pressure) within < 120/75 mmHg (I11.0).
Common Symptoms & Clinical Signs
- • Presentation of Hypertensive heart disease with heart failure (I11.0): persistently elevated home in Hypertensive heart disease with heart failure (I11.0: or clinic blood)
- • Secondary Hypertensive heart disease with heart failure clinical sign: morning occipital headache, in Hypertensive heart disease with heart failure (I11.0: pulsatile tinnitus, or)
- • Symptom flares in Hypertensive heart disease with heart failure correlating with Urine Albumin-to-Creatinine Ratio [Hypertensive heart disease with heart failure I11.0] deviation outside < 15 mg/g (I11.0)
- • Functional blood pressure impact requiring vascular stiffness assessment [Hypertensive heart disease with heart failure I11.0] evaluation (I11.0)
Hypertensive heart disease with heart failure Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I11.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [Hypertensive heart disease with heart failure I11.0] | < 15 mg/g (I11.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Home Seated Blood in Hypertensive heart disease with heart failure (I11.0: Pressure) | < 120/75 mmHg (I11.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Ankle-Brachial Index (ABI) [Hypertensive heart disease with heart failure I11.0] | 1.00 – 1.30 (I11.0) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Hypertensive heart disease with heart failure
Treatment selection for Hypertensive heart disease with heart failure depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Hypertensive heart disease with heart failure)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Randomized trials of telmisartan versus active controls for insulin resistance in: What a 2,033-Participant Study Found When data from all the 33 trials were pooled, telmisartan was associated with statistically significant reductions in percent changes of insulin levels (-10.92%; -15.60% to -6.23%; P < .00001) and HOMA-IR (-15.89%; -22.01% to... Journal of the American Society of Hypertension : JASH • 2014-08-15 • Meta-Analysis | N = 2,033 | 99/100 | PMID 25151319 ↗ |
| New Insights on Major outcomes in high-risk hypertensive patients randomized to: What a 9,048-Participant Study Found Thiazide-type diuretics are superior in preventing 1 or more major forms of CVD and are less expensive. JAMA • 2002-12-18 • Randomized Controlled Trial | N = 9,048 | 96/100 | PMID 12479763 ↗ |
| New Insights on Heart and blood vessel outcomes in high-risk hypertensive patients stratified by: What a 8,126-Participant Study Found Older high-risk patients with high blood pressure and reduced GFR are more likely to develop CHD than to develop ESRD. Annals of internal medicine • 2006-02-07 • Randomized Controlled Trial | N = 8,126 | 96/100 | PMID 16461961 ↗ |
| New Insights on Three Low-Dose blood-pressure-lowering Agents in a Single Pill after: What a 1,670-Participant Study Found Among patients with intracerebral hemorrhage, treatment with a combination of three low-dose blood-pressure-lowering agents in a single pill, in addition to standard care, was associated with a lower incidence of recurrent... The New England journal of medicine • 2026-04-23 • Phase III Randomized Trial | N = 1,670 | 96/100 | PMID 42019018 ↗ |
| New Insights on Safety of long-acting dihydropyridine calcium channel blockers in hypertensive: What a 32,920-Participant Study Found The incidence rates for MI and other cardiac events were low in these high blood pressure trials, and did not differ among treatment groups in either the amlodipine or nifedipine GITS comparative analyses. The American journal of cardiology • 1998-01-15 • Meta-Analysis | N = 32,920 | 94/100 | PMID 9591899 ↗ |
Hypertensive heart disease with heart failure Patient Community & “People Like Me” Threads
Filter Hypertensive heart disease with heart failure community threads and patient logs by age, biological sex, dosage, and treatment duration.